Search

everythinglearnresearchcommunity

for

Search:↓

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

COVID-19 may harm male fertility and damage the reproductive system.

We need better ways to test and understand SARMs to make safer and more effective treatments.

MC4R gene variants not linked to female hair loss.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

The conclusion is that combining social and cultural factors with pharmaceutical research could improve our understanding of how drugs work.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

Some medicinal plants can help heal wounds and may lead to new treatments.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

COVID-19 may cause hair loss due to infection stress or treatments.

Macrophages help hair growth after injury through CX3CR1 and TGF-β1.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Antibody treatments show promise for hair loss but need more research.

Metal organic frameworks-based scaffolds show promise for tissue repair due to their unique properties.

High-resolution imaging is crucial for diagnosing and planning treatments in clinical anatomy and aging.

Eating disorders can cause hair loss.